6-Fluoro-4-methylpyridine-3-carboxylic acid → HCID 58484588, 화합물
반응식
[F:1][C:2]1[CH:10]=[C:9]([CH3:11])[C:5]([C:6]([OH:8])=O)=[CH:4][N:3]=1.[CH:12]1([C:15]2[CH:20]=[C:19]([CH:21]3[CH2:23][CH2:22]3)[CH:18]=[CH:17][C:16]=2[N:24]2[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]2)[CH2:14][CH2:13]1>>[CH:12]1([C:15]2[CH:20]=[C:19]([CH:21]3[CH2:23][CH2:22]3)[CH:18]=[CH:17][C:16]=2[N:24]2[CH2:25][CH2:26][N:27]([C:6]([C:5]3[CH:4]=[N:3][C:2]([F:1])=[CH:10][C:9]=3[CH3:11])=[O:8])[CH2:28][CH2:29]2)[CH2:13][CH2:14]1참가 물질
3
실험 절차
Using 6-fluoro-4-methylnicotinic acid (386 mg) and 1-(2,4-dicyclopropylphenyl)piperazine (650 mg) described in Preparation Example 101 and by the reaction and treatment in the same manner as in Preparation Example 118, the title compound (980 mg) was obtained.
후처리
- customdescribed in Preparation Example 101 and by the reaction and treatment in the same manner as in Preparation Example 118
출처 및 근거
- ORD 기록
- ord-2857f953ab9e4c88a45d7b07ef7bb419
- 출처 데이터셋
- uspto-grants-2014_08
- 특허 번호
- US08816079B2
반응 노트
불러오는 중…